Literature DB >> 6173286

Clinical and experimental studies on the profiles of serum proteins in acute hepatic injury.

T Imanishi.   

Abstract

The change with time in profiles of five serum proteins in acute hepatitis were studied. Prealbumin (Pre) decreased in the initial stage and made a peak to be normal thereafter. Alpha 1 antitrypsin (alpha 1AT) showed a slight increase in the initial stage but no remarkable change thereafter. Haptoglobin (Hp) decreased in the initial stage and then increased gradually to be normal. Alpha 2HS glycoprotein (alpha 2HS) and beta 1CA globulin (beta 1CA) showed no decrease, but they later increased in the 2nd or 3rd week. In fulminant hepatitis, alpha 1AT was somewhat high in the initial stage but decreased gradually to the lower normal limits; Pre and Hp decreased markedly; and alpha 2HS and beta 1C/A decreased from the initial stage. Alpha 2HS and beta 1C/A were found useful for estimation of the severity of acute hepatitis in the initial stage. It was found that when Hp showed a marked decrease, especially ahaptoglobinemia, the hepatic injury was serious. Various degrees of hepatic injury were produced by Gal-N in rats and mice were compared with the amount of these proteins. The level of albumin (Al), transferrin (Tr), alpha 1AT and Hp was inversely proportional to the amount of liver cell necrosis, Particularly, Hp showed a marked decrease in submassive or massive necrosis, while a moderate decrease in minimal change of focal necrosis. Al and Tr showed a slight decrease of about the same degree, and the decrease of alpha 1AT was somewhat greater. beta 1C/A decreased in inversely proportion with the amount of liver cell necrosis and its decrease in massive necrosis was more pronounced than the other proteins.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6173286     DOI: 10.1007/BF02774521

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  20 in total

1.  Serum haptoglobins in hepatobiliary disease.

Authors:  J A OWEN; I R MACKAY
Journal:  Br Med J       Date:  1959-06-06

2.  Studies on the inhibition of glycogenolysis by D-galactosamine in rat liver hepatocytes.

Authors:  S R Wagle; R Stermann; K Decker
Journal:  Biochem Biophys Res Commun       Date:  1976-07-26       Impact factor: 3.575

3.  Studies on the relationship between the histological changes and liver cell function or plasma proteins in hepatic diseases.

Authors:  I Sakumoto; N Kikuchi; T Takane; H Yoshida; H Hosaka
Journal:  Gastroenterol Jpn       Date:  1976

4.  Metabolism of the third component of complement in acute type B hepatitis, HBs antigen positive glomerulonephritis, polyarteritis nodosum, and HBs antigen positive and negative chronic active liver disease.

Authors:  H C Thomas; B J Potter; E Elias; S Sherlock
Journal:  Gastroenterology       Date:  1979-04       Impact factor: 22.682

5.  The inhibition of rat liver nuclear ribonucleic acid synthesis by galactosamine and its reversal by uridine.

Authors:  Y Konishi; H Shinozuka; J L Farber
Journal:  Lab Invest       Date:  1974-06       Impact factor: 5.662

6.  D-galactosamine and acute liver cell injury.

Authors:  H Shinozuka; J L Farber; Y Konishi; T Anukarahanonta
Journal:  Fed Proc       Date:  1973-04

7.  Isolation and biochemical characterization of alpha-2-opsonic glycoprotein from rat serum.

Authors:  F Blumenstock; P Weber; T M Saba
Journal:  J Biol Chem       Date:  1977-10-25       Impact factor: 5.157

8.  Serum proteins in diseases of the liver.

Authors:  S Skrede; J P Blomhoff; K Elgjo; E Gjone
Journal:  Scand J Clin Lab Invest       Date:  1975-09       Impact factor: 1.713

9.  BA and SH antigen in chronic hepatitis.

Authors:  P J Grob; H J Jemelka; J W Müller
Journal:  Gastroenterology       Date:  1971-07       Impact factor: 22.682

10.  The interpretation of haptoglobin values in the diagnosis of liver disease.

Authors:  L Kallai; M Keler-Bacoka; K Blazević; S Knezević
Journal:  Gastroenterologia       Date:  1966
View more
  5 in total

1.  Profiles of acute-phase reactants and clinical significance of alpha 2-macroglobulin in acute hepatitis B.

Authors:  J Van Gool
Journal:  Inflammation       Date:  1983-09       Impact factor: 4.092

2.  Selective expression of transthyretin in subtypes of lung cancer.

Authors:  Shuai Hao; Suozhu Sun; Xueyuan Xiao; Dacheng He; Liyun Liu
Journal:  J Mol Histol       Date:  2016-03-04       Impact factor: 2.611

3.  Telbivudine treatment corrects HBV-induced epigenetic alterations in liver cells of patients with chronic hepatitis B.

Authors:  Yi Tian; Dongjing Ni; Weibing Yang; Yi Zhang; Keji Zhao; Jianxun Song; Qing Mao; Zhiqiang Tian; Jennifer C van Velkinburgh; Di Yang; Yuzhang Wu; Bing Ni
Journal:  Carcinogenesis       Date:  2013-09-25       Impact factor: 4.944

4.  Potential biomarkers in the sera of breast cancer patients from bahawalpur, pakistan.

Authors:  Faiz-Ul-Hassan Nasim; Samina Ejaz; Muhammad Ashraf; Abdul Rehman Asif; Michael Oellerich; Gulzar Ahmad; Gulzar Ahmad Malik
Journal:  Biomark Cancer       Date:  2012-12-10

5.  Comparative Proteomic Study of the Antiproliferative Activity of Frog Host-Defence Peptide Caerin 1.9 and Its Additive Effect with Caerin 1.1 on TC-1 Cells Transformed with HPV16 E6 and E7.

Authors:  Guoying Ni; Di Liang; Scott F Cummins; Shelley F Walton; Shu Chen; Yuejian Wang; Kate Mounsey; Ming Q Wei; Jianwei Yuan; Xuan Pan; Xiaosong Liu; Tianfang Wang
Journal:  Biomed Res Int       Date:  2018-05-13       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.